The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose is a research paper published in Clinical Gastroenterology and Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: OT2OD024899
National Institutes of Health
Grant: U54 DK123755
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK122015
FWCI
0.92
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals